Prime Medicine, Inc.

Nasdaq PRME · Cambridge, MA

Works in Genetic & rare · GI & liver · Hematology · Immunology · Metabolic & endocrine · Neurology · Respiratory

Prime Medicine, Inc. is a clinical trial sponsor based in Cambridge, MA, listed as Nasdaq PRME. It has 4 active clinical trials with 138 planned participants, across 7 therapeutic areas.

Trial track record · since 2021

4Active trials138 planned participants
0Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

Financials · Nasdaq PRME

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 4 active trials

StageTrialStatus

Questions about Prime Medicine, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-21.

Approve Suite is not affiliated with Prime Medicine, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.